Carbamate Poisoning Management

Critical Initial Management

The American Heart Association recommends using appropriate personal protective equipment when caring for patients with carbamate exposure to prevent contamination of healthcare providers 1
Immediate removal of all contaminated clothing and performing copious irrigation with soap and water for external exposure is recommended 1, 2
Early endotracheal intubation should be performed for life-threatening carbamate poisoning, particularly when bronchorrhea, bronchospasm, or altered mental status threatens airway protection 1, 2
Neuromuscular blockers metabolized by cholinesterase (succinylcholine and mivacurium) should be avoided as they are contraindicated in carbamate poisoning 1, 2

Atropine should be administered 1-2 mg IV for adults (0.02 mg/kg for children, minimum 0.1 mg, maximum single dose 0.5 mg) immediately for severe manifestations including bronchospasm, bronchorrhea, seizures, or significant bradycardia 1, 2
The dose of atropine should be doubled every 5 minutes until full atropinization is achieved (clear chest on auscultation, heart rate >80/min, systolic blood pressure >80 mm Hg, dry skin and mucous membranes) 1, 2
Atropinization should be maintained with continuous infusion after initial bolus dosing 1, 2
Benzodiazepines (diazepam first-line or midazolam) should be administered to treat seizures and agitation in carbamate poisoning 1, 2

Supplemental oxygen and support ventilation should be provided as needed 2
IV access should be established and fluids administered for volume resuscitation 2
Continuous cardiac monitoring should be performed for dysrhythmias 2
Patients should be monitored closely for at least 48-72 hours as delayed complications can occur 2

Atropine administration should never be delayed—it is the immediate life-saving intervention with Class 1, Level A evidence 1, 2
Atropine should not be underdosed—carbamate poisoning often requires much higher doses than typical bradycardia treatment 1, 2
Pralidoxime should not be withheld when the poison class is unknown, as organophosphate poisoning is clinically indistinguishable from carbamate poisoning and requires early oxime therapy 2
Succinylcholine or mivacurium should be avoided for intubation as they are metabolized by cholinesterase 1
Poison control (1-800-222-1222 in the US) should be contacted for expert guidance on specific case management 3

Patients should be watched for aspiration pneumonia from bronchorrhea 2
Monitoring for rhabdomyolysis and renal damage is recommended, though this is more common with organophosphates 2
Central nervous system effects including hallucinations and fever from high-dose atropine therapy should be assessed 2